| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/03/1994 | EP0608809A1 Antiviral tetrahydropyrans |
| 07/27/1994 | EP0607607A1 Xanthine derivatives |
| 07/26/1994 | US5332814 Process for the preparation of carbacyclic nucleosides, and intermediates |
| 07/26/1994 | US5332744 Hypotensive, congestive heart failure, intraocular pressure |
| 07/26/1994 | CA2111549A1 Antiviral tetrahydropyrans |
| 07/21/1994 | WO1994015606A1 Olefin-substituted long chain compounds |
| 07/21/1994 | WO1994015605A1 Acetal or ketal substituted therapeutic compounds |
| 07/21/1994 | CA2153698A1 Olefin-substituted long chain compounds |
| 07/20/1994 | EP0606248A1 Heteroaryl amines as novel acetyl cholinesterase inhibitors |
| 07/19/1994 | CA1330797C Alkoxy methyl ether and alkoxy methyl ester derivatives |
| 07/19/1994 | CA1330794C Anti-viral compounds, dosage forms and methods |
| 07/12/1994 | US5329008 From a purinone alcohol by protection, cyanation, double bond isomerization, hydrolysis, reduction and cis-dihydroxylation |
| 07/12/1994 | US5329007 Selective adenosine receptor agents |
| 07/12/1994 | CA1330659C Alkoxy methyl ether and alkoxy methyl ester derivatives |
| 07/07/1994 | WO1994014802A1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| 07/06/1994 | EP0342203B1 2',3' dideoxyribofuranoxide derivatives |
| 06/29/1994 | CN1088577A Novel multi-drug resistance modifier |
| 06/28/1994 | US5324730 Viricides |
| 06/25/1994 | CA2112031A1 Xanthine derivatives |
| 06/23/1994 | WO1994013668A1 Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds |
| 06/23/1994 | WO1994003467A3 Antiretroviral enantiomeric nucleotide analogs |
| 06/23/1994 | CA2117462A1 New pyrimidine bicyclic compounds; process for preparing the same; pharmaceutical compositions containing them |
| 06/22/1994 | EP0602246A1 Isoindazole compound |
| 06/22/1994 | CN1088259A Caffeine demethylase gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine |
| 06/22/1994 | CN1088209A Heterocyclic compounds |
| 06/22/1994 | CA2085969A1 6-azido-2-fluoropurine and its use in the synthesis of nucleosides |
| 06/15/1994 | CN1087893A Technology for integrative extraction of theapolyphenols, caffein, chlorophyll and protein from tea leaves |
| 06/14/1994 | US5321029 Vascular and skin disorders; bronchodilator |
| 06/09/1994 | WO1994012188A1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 06/07/1994 | US5319080 Antiviral agents |
| 06/07/1994 | US5318974 Amino acid esters of pyrimidine; used in the treatment of herpes virus infections |
| 06/01/1994 | DE4342568A1 Chewing gum contg. caffeine - used as substitute for coffee, tea, cola, etc. and to control fatigue and migraine |
| 05/31/1994 | US5317023 2-Phenyl-(imidazo(4,5-b)pyridyl-methyl-) derivatives; hypertensive agents; cognition activators |
| 05/26/1994 | WO1994011370A1 Substituted amino alkyl compounds |
| 05/26/1994 | WO1994011001A1 Hydroxyl-containing compounds |
| 05/26/1994 | WO1994011000A1 Xanthine derivatives for use as diuretics |
| 05/26/1994 | CA2151617A1 Hydroxyl-containing compounds |
| 05/26/1994 | CA2148473A1 Xanthine derivatives for use as diuretics |
| 05/24/1994 | US5314893 Antiviral tetrahydropyrans |
| 05/24/1994 | US5314890 Treatment of asthma |
| 05/19/1994 | DE4238367A1 Diuretisches Mittel Diuretic agents |
| 05/18/1994 | EP0597377A1 Process for the production of 3,7-Dialkylxanthine from 3-Alkylxanthine |
| 05/18/1994 | CN1086818A Asymmetrically substituted xanthines |
| 05/17/1994 | US5312963 Process for preparing substituted cyclobutanes |
| 05/17/1994 | CA1329595C Method for decaffeinating coffee materials including a reverse osmosis permeate recycle |
| 05/17/1994 | CA1329475C Stable chemical compositions containing chromogenic materials or mixtures of chromogenic materials and peroxides, and stabilizing chemical compositions and methods for obtaining the stable chemical compositions |
| 05/11/1994 | WO1994009793A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 05/11/1994 | EP0596542A1 Therapeutic nucleosides |
| 05/10/1994 | US5310916 Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors |
| 05/10/1994 | US5310666 Process for the enantioselective preparation of (β-1)-hydroxyalkylxanthines by reduction using Rhodotorula rubra |
| 05/04/1994 | EP0594677A1 Antiviral liponucleosides: treatment of hepatitis b |
| 04/28/1994 | WO1994005296A3 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 04/27/1994 | EP0593562A1 Tropical composition containing penciclovir |
| 04/26/1994 | US5306837 Antiviral agents |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/20/1994 | CN1024278C Process for preparation of 8-substituted nucleoside and derivative of purine & their use |
| 04/19/1994 | CA1328612C Cosmetic composition having an anti-cellulitis and slimming action in which the active ingredient is a 1-hydroxyalkyxanthin |
| 04/14/1994 | WO1994007892A1 Process for the preparation of 2-amino-6-chloropurine |
| 04/14/1994 | WO1994007858A1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers |
| 04/13/1994 | CN1024198C Process for preparing adenosine derivatives |
| 04/12/1994 | CA1328404C Pharmaceutical combination product and the preparation and use thereof |
| 04/06/1994 | EP0590919A1 Therapeutic agents for parkinson's disease |
| 04/06/1994 | EP0590361A1 Process for the preparation of 2-amino-6-halopurines |
| 04/05/1994 | US5300519 Immunosuppressive agents |
| 04/05/1994 | US5300509 2-furyl-oxazolo[5,4-d]-pyrimidines |
| 04/05/1994 | US5300508 Method for intercepting activated species of dioxygen |
| 04/05/1994 | US5300298 Methods of treating obesity with purine related compounds |
| 03/31/1994 | WO1994006776A1 Process of synthesizing useful intermediates of substituted imidazole compounds |
| 03/31/1994 | WO1994006431A1 Novel epoxide-containing compounds |
| 03/31/1994 | WO1994006423A1 Novel use of inhibitors of phosphodiestersase iv |
| 03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
| 03/31/1994 | CA2144510A1 Novel use inhibitors of phosphodiestersase iv |
| 03/29/1994 | US5298508 Irreversible inhibitors of adenosine receptors |
| 03/23/1994 | EP0587814A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |
| 03/17/1994 | WO1994005296A2 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 03/17/1994 | WO1994005258A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof |
| 03/17/1994 | WO1993017020A3 Therapeutic nucleosides |
| 03/17/1994 | DE4230464A1 New imidazolyl-benzimidazole or related cpds. - useful as angiotensin II antagonists for treating cardiovascular or CNS disorders, etc. |
| 03/17/1994 | CA2142493A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-¬(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof |
| 03/17/1994 | CA2141425A1 Nitrogen substituted acridine and cytochrome p450 inhibitors and methods of use |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586523A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/16/1994 | CN1083813A Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process |
| 03/16/1994 | CN1083812A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/16/1994 | CA2078256A1 Synthesis of sulfide-linked di-or oligonucleotide analogs and incorporation into antisense dna or rna |
| 03/03/1994 | WO1994004154A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE-NUCLEOSIDES |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584223A1 Novel immunosuppressive compounds |
| 03/02/1994 | EP0584068A1 Method and composition for ameliorating the adverse effects of aging |
| 03/02/1994 | EP0584062A1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins |
| 03/01/1994 | US5290801 Benzimidazoles for the treatment of atherosclerosis |
| 03/01/1994 | US5290782 Xanthine derivatives |
| 02/23/1994 | EP0583498A1 Improved caffeine recovery from activated carbon |
| 02/23/1994 | CN1082546A 7-Neopentyl xanthine derivatives, their preparation and pharmaceutical compositions containing them |
| 02/22/1994 | US5288721 Substituted epoxyalkyl xanthines |
| 02/19/1994 | CA2100694A1 Improved caffeine recovery from activated carbon |
| 02/17/1994 | WO1994003467A2 Antiretroviral enantiomeric nucleotide analogs |
| 02/17/1994 | WO1994003456A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties |
| 02/17/1994 | DE4325254A1 New asymmetrically substd. xanthine derivs. - useful as adenosine antagonist(s), cholinomimetic(s) and diuretic(s), in treatment of Parkinsonism, depression, dyslexia, cystic fibrosis, etc. |